Work

Abstract 3796: Targeting midkine with HBS-101 enhances chemotherapy and immunotherapy response in TNBC via immune activation and oncogenic pathway suppression

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-3796

Authors: Baskaran Subramani, Megharani R. Mahajan, Panneerdoss Subbarayalu, Zhenming Xu, Neelam Mukherjee, Gangadhara R. Sareddy, Hareesh B. Nair, Ratna K. Vadlamudi, Suryavathi Viswanadhapalli

Institutions: The University of Texas at San Antonio, The University of Texas at San Antonio Health Science Center, Texas Tech University

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148853995

Cites:

Cited by:

Related to: